Related Experiment Video
Updated: May 10, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Abnormalities of the cardiac stem and progenitor cell compartment in experimental and human diabetes
Anna Leonardini1, Angelo Avogaro
1Department of Emergency and Organ Transplantation - Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro , Bari , Italy and.
Insights
Diabetic cardiomyopathy involves cardiac stem cell dysfunction. Preserving these cells may counteract diabetes-related heart damage, though cell therapy requires further research.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Metabolic Disease Research
Background:
- Diabetic cardiomyopathy presents structural and functional cardiac changes.
- Cardiac stem/progenitor cells (CSPC) are implicated in diabetic cardiomyopathy pathophysiology.
- Diabetes negatively impacts CSPC number and function.
Purpose of the Study:
- To review the role of CSPC in diabetic cardiomyopathy.
- To explore how diabetes-induced factors affect CSPC.
- To assess the potential of CSPC preservation and cell therapy.
Main Methods:
- Literature review of recent studies on CSPC in diabetic hearts.
- Analysis of the impact of hyperglycemia, hyperlipidemia, inflammation, and oxidative stress on CSPC.
- Evaluation of the therapeutic potential of CSPC preservation and cell-based strategies.
Main Results:
- Diabetic hearts show reduced numbers and impaired proliferation of CSPC.
- Hyperglycemia, hyperlipidemia, inflammation, and oxidative stress contribute to CSPC defects.
- An imbalance between CSPC death and replacement promotes diabetic cardiomyopathy progression.
Conclusions:
- The CSPC compartment is crucial in diabetic cardiomyopathy.
- Preserving CSPC may offer a strategy to mitigate diabetic cardiac damage.
- Further research is needed to establish cell therapy as a clinical option.
Abstract:
Diabetic cardiomyopathy consists of a series of structural and functional changes. Accumulating evidence supports the concept that a "cardiac stem cell compartment disease" plays an important role in the pathophysiology of diabetic cardiomyopathy. In diabetic hearts, human cardiac stem/progenitor cells (CSPC) are reduced and manifest defective proliferative capacity. Hyperglycaemia, hyperlipidemia, inflammation, and the consequent oxidative stress are enhanced in diabetes: these conditions can induce defects in both growth and survival of these cells with an imbalance between cell death and cell replacement, thus favouring the onset of diabetic cardiomyopathy and its progression towards heart failure. The preservation of CSPC compartment can contribute to counteract the negative impact of diabetes on the myocardium. The recent studies summarized in this review have improved our understanding of the development and stem cell biology within the cardiovascular system. However, several issues remain unsolved before cell therapy can become a clinical therapeutically relevant strategy.
Related Concept Videos
Tissue Renewal without Stem Cells
However, failure of such a system...
Stem Cell Culture
